REDUCE LAP-HF RANDOMIZED TRIAL I

Running, not enrolling · Not applicable

Conditions studied: Heart Failure

In brief

A study to evaluate the Corvia Medical, Inc. IASD® System II to REDUCE Elevated Left Atrial Pressure in Patients with Heart Failure.

Key facts

Study ID

NCT02600234

Run by

Corvia Medical

People needed

44

Starts

2015-12-01

Expected to finish

2026-08-01

Last updated by the study team

2023-03-10

Who can join

Age: 40 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• University of Arizona College of Medicine — Tucson, Arizona, United States
• Yale University — New Haven, Connecticut, United States
• Northwestern University — Chicago, Illinois, United States
• Evanston Northshore Healthcare — Evanston, Illinois, United States
• Cardiovascular Institute of the South — Houma, Louisiana, United States
• Ochsner Medical Center — New Orleans, Louisiana, United States
• Massachusetts General Hospital — Boston, Massachusetts, United States
• University of Michigan Health System — Ann Arbor, Michigan, United States
• Mayo Clinic — Rochester, Minnesota, United States
• Columbia University Medical Center/NewYork Presbyterian Hospital — New York, New York, United States
• Mt. Sinai Hospital — New York, New York, United States
• New York University — New York, New York, United States
• Wake Forest — Winston-Salem, North Carolina, United States
• Ohio Health — Columbus, Ohio, United States
• Ohio State University College of Medicine — Columbus, Ohio, United States
• University of Pennsylvania — Philadelphia, Pennsylvania, United States
• Medical University of South Carolina — Charleston, South Carolina, United States
• The Alfred Hospital — Melbourne, Australia
• OLVZ Aalst — Aalst, Belgium
• UMC Groningen — Groningen, Netherlands
• Golden Jubilee Hospital — Glasgow, United Kingdom

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.